Jim Simons Windtree Therapeutics Inc Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.16 - $281.7 $3,856 - $6.79 Million	24,100 Added 7.73%	335,700 $57,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $306.0 $14,938 - $15.2 Million	-49,795 Reduced 13.78%	311,600 $94,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $1.14 $48,240 - $144,721	126,949 Added 54.15%	361,395 $151,000
Q1 2022 May 13, 2022	BUY	$0.94 - $1.6 $17,809 - $30,313	18,946 Added 8.79%	234,446 $267,000
Q4 2021 Feb 11, 2022	BUY	$1.4 - $2.31 $39,340 - $64,911	28,100 Added 14.99%	215,500 $346,000
Q3 2021 Nov 12, 2021	BUY	$1.66 - $2.27 $69,222 - $94,659	41,700 Added 28.62%	187,400 $386,000
Q2 2021 Aug 13, 2021	BUY	$1.68 - $2.79 $225,288 - $374,139	134,100 Added 1156.03%	145,700 $334,000
Q1 2021 May 13, 2021	BUY	$2.14 - $6.18 $24,824 - $71,688	11,600 New	11,600 $28,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.